Developing monoclonal antibody therapies for measles could lead to adverse pathogen evolution

Key Points

• The aim is to examine the implications of monoclonal antibody therapies for measles and their effect on virus evolution.
• Analysis of monoclonal antibody therapies in the context of measles
• Review of recent measles virus resurgence and vaccination effectiveness
• Consideration of evolutionary biology regarding pathogen adaptation.
• Monoclonal antibody therapies could facilitate measles virus evolution.
• Evolution of the virus might reduce vaccine effectiveness.
• Potential adverse effects may outweigh the benefits of these therapies.